Encephalitis and myelitis study using new DNA testing
Part of Brain & nervous system, Infections clinical trials.
This study uses new genetic testing to find the cause of brain or spinal cord inflammation in people in Guadeloupe. If you or your child has sudden symptoms like confusion, memory loss, or weakness, this trial may help identify the underlying infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 28 days old.
- Your symptoms started suddenly and have lasted more than 24 hours.
- You have major symptoms like confusion, memory loss, or extreme tiredness, plus at least two minor symptoms like fever, seizures, or abnormal spinal fluid.
- If you have spinal cord inflammation, you need abnormal MRI or spinal fluid results and symptoms that got worse in less than 4 weeks.
- You cannot have other clear causes like a brain abscess, tumor, or certain autoimmune diseases.
- You must have health insurance and sign a consent form (or have a legal guardian sign).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for new ways to find the cause of lymphocytic meningitis or meningoencephalitis (inflammation of the brain or its lining) when standard tests don't give an answer. It may help people who have been hospitalized with these conditions and whose spinal fluid tests were unclear or not done.
This study looks at what causes severe seizure episodes (“status epilepticus”) and a related immune condition that affects the brain (“dysimmune encephalitis”). The goal is to better understand the disease process, which may guide future care.
This study looks at children who have had a first attack of nerve inflammation (like ADEM, vision loss, or spinal cord issues) to find markers in the blood that might show if it will come back. It tests blood and cells to better understand the immune response.
This study uses a new, advanced DNA sequencing method to look for a specific type of genetic change (called 'repeat expansion') that may cause neurological disorders. The goal is to help people who have a neurological condition but whose standard genetic tests did not find the cause.
This research study looks for new markers in the blood of people with autoimmune encephalitis (a condition where the immune system attacks the brain). It aims to better understand what causes the disease and find new ways to diagnose it.
This study uses a newer, more detailed type of genetic testing (long-read genome sequencing) to look for the cause of severe childhood epilepsy and developmental delays when standard testing has found nothing. The goal is to find answers for families who have gone without a diagnosis.
Hear when a new Acute Encephalitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.